Ventyx Biosciences, Inc. 4 SEC Filings

Filed On	Filing
04 Mar 2026	Form 4: Gonzales Roy, Senior VP, Finance Returned 5,313 shares to the issuer · Disposed of 281,700 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Subramaniam Somu, Director Returned 3,337,495 shares to the issuer · Disposed of 130,762 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: White William Richard, Director Disposed of 249,882 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Moore Matthew Richard, Chief Operating Officer Disposed of 465,000 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Cadoret-Manier Onaiza, Director Disposed of 129,364 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Hulme Allison, Director Disposed of 129,364 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Gujrathi Sheila, Director Returned 130,000 shares to the issuer · Disposed of 1,131,072 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Nuss John, CHIEF SCIENTIFIC OFFICER Returned 489,481 shares to the issuer · Disposed of 9,063 Restricted Stock Units (Disposition to Issuer) · Disposed of 1,307,604 Stock Option (right to buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Mohan Raju, Director Returned 2,372,863 shares to the issuer · Disposed of 23,688 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,792,930 Stock Option (Right to Buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Forman Mark S, Chief Medical Officer Returned 6,000 shares to the issuer · Disposed of 435,000 Stock Option (Right to Buy) (Disposition to Issuer)
03 Mar 2026	Form 4: Subramaniam Somu, Director Disposed of 694,718 shares (Other Transaction)
19 Dec 2025	Form 4: Mohan Raju, Director Received 116,668 shares by exercise or conversion · Sold 47,345 shares ($365K)
19 Dec 2025	Form 4: Nuss John, CHIEF SCIENTIFIC OFFICER Received 34,930 shares by exercise or conversion · Sold 12,675 shares ($97.8K)
19 Nov 2025	Form 4: Forman Mark S, Chief Medical Officer Received 3,000 shares as a grant or award ($3.09K)
19 Nov 2025	Form 4: Gonzales Roy, Senior VP, Finance Received 1,767 shares as a grant or award ($1.82K)
06 Jun 2025	Form 4: Cadoret-Manier Onaiza, Director Granted 40,000 Stock Option (Right to Buy)
06 Jun 2025	Form 4: Hulme Allison, Director Granted 40,000 Stock Option (Right to Buy)
06 Jun 2025	Form 4: Subramaniam Somu, Director Granted 40,000 Stock Option (Right to Buy)
06 Jun 2025	Form 4: White William Richard, Director Granted 40,000 Stock Option (Right to Buy)
06 Jun 2025	Form 4: Gujrathi Sheila, Director Granted 40,000 Stock Option (Right to Buy)

Comments